As Suno inks deals with Warner and BMG, UMG and Sony argue those licenses prove a market exists-potentially sinking its fair-use defense.

Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.

The winding-down RSN operator claims cable giants shortchanged regional sports networks, a fight with billions in implications.